NASDAQ · ALMR
Alamar Biosciences, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for ALMR: Nov 03, 2026
Alamar Biosciences, Inc. Common Stock is expected to report earnings on 11/03/2026 after market close. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 3 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.22.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-0.22 | $-0.15 | $-0.26 | 3 |
| Dec 2026 | $-0.20 | $-0.18 | $-0.21 | 2 |
| Mar 2027 | $-0.16 | $-0.16 | $-0.16 | 1 |
| Jun 2027 | $-0.15 | $-0.15 | $-0.15 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · The Motley Fool · MarketBeat- RTTNews · Oct 29, 2:08 AM EDTAlamar Biosciences' Protein Signature Detects ALS With 98.3% Accuracy In Study(RTTNews) – Alamar Biosciences, Inc. (ALMR) announced that researchers at Emory University have identified a 10-protein blood signature that distinguished people with amyotrophic lateral sclerosis from healthy individuals with 98.3% balanced accuracy in an independent validation
- RTTNews · Oct 7, 7:25 AM EDTBiotech Stocks At 52-Week Highs – PACB, FTRE, ALMR, TXG, AZTA(RTTNews) – The following biotech stocks reached a 52-week high on October 6, 2026, driven by key catalysts such as newly announced research collaborations.
- The Motley Fool · Aug 17, 8:14 PM EDTAlamar Biosciences (ALMR) Q2 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- RTTNews · Aug 12, 3:45 AM EDTBiotech Stocks At 52-Week Highs – ALMR +30% On Q2 Reports, DYN, CGEM, DXCM, CAH(RTTNews) – The following biotech stocks reached a 52-week high on August 11, 2026, driven up by key catalysts such as positive quarterly or full year reports.
- RTTNews · Aug 11, 10:51 AM EDTAlamar Biosciences' Q2 Revenue Surges 82%; Provides FY26 Revenue Guidance(RTTNews) – Shares of Alamar Biosciences, Inc. (ALMR) are up over 16% today. The precision proteomics company recently reported its second-quarter 2026 financial results, with investors focusing on strong revenue growth, a sharp increase in consumable sales, new product launches
- MarketBeat · Aug 10, 6:04 PM EDTAlamar Biosciences Q2 Earnings Call HighlightsAlamar Biosciences (NASDAQ:ALMR) reported second-quarter 2026 revenue of $29.4 million, up 82% from $16.2 million a year earlier, as growth in consumables, instrument placements and service revenue supported the company’s first earnings call since completing its April initial pub
- RTTNews · Jul 29, 6:09 AM EDTAlamar Launches NULISAseq Immune 340 Panel To Advance Immune Profiling And Proteomics Research(RTTNews) – Alamar Biosciences, Inc. (ALMR), a commercial-stage proteomics company, announced the launch of NULISAseq Immune 340 Panel, a multiplexed immune profiling solution for translational research and drug development.
- RTTNews · Jul 14, 4:03 AM EDTBiotech Stocks At 52-Week Highs – COAG, ALMR, PGNY, TXG, VMD(RTTNews) – The following biotech stocks touched a 52-week high on July 14, 2026, attributable to key catalysts like encouraging clinical trial results and the launch of new programs supporting research advancements.
- RTTNews · Jul 13, 5:26 AM EDTAlamar Biosciences Partners With Leading Research Universities On National Biomarker Initiative(RTTNews) – Alamar Biosciences, Inc. (ALMR), a precision proteomics company focused on advancing early disease detection, announced a partnership with leading U.S. research universities to launch a national-scale initiative profiling blood-based biomarkers for Alzheimer's disease
- RTTNews · Jul 7, 11:31 AM EDTAlamar Biosciences Launches EMTBR-Tau Immunoassay For Alzheimer's Disease(RTTNews) – Alamar Biosciences, Inc. (ALMR), a commercial-stage proteomics company, announced on Tuesday the commercial launch of a multiplexed blood-based immunoassay for eMTBR-Tau, a biomarker associated with Alzheimer's disease. Alzheimer's disease is a progressive neurodege
- The Motley Fool · Jun 23, 11:27 AM EDTCathie Wood Goes Bargain Hunting: 3 Stocks She Just BoughtCathie Wood added to her positions in SpaceX, Roblox, and Alamar Biosciences on Monday.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Alamar Biosciences, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.